PepGen Inc. Insider Trading
PEPG
Insiders sold 59K and bought nothing on the open market.
All of the selling was scheduled in advance under 10b5-1 plans. The last open-market buy by an executive or director was in May 2025.
Get an email when PEPG's executives or directors buy, or make a large sale outside a plan.
Trades · last 2 years
| Date | Insider | Trade | Shares | Price | Value | Of their stake | Filing |
|---|---|---|---|---|---|---|---|
| Nov 13 | RA Capital Management, L.p. Large holder | Bought | 8,625,000 | $5.00 | $43.1M | 46% | Form 4 |
| May 21 | Kasra Kasraian Chief Technical Officer | Sold10b5-1 plan | 1,233 | $1.41 | 2K | 2.4% | Form 4 |
| Mar 4 | Paul Streck EVP, Head of R&D | Sold10b5-1 plan 2 parts | 1,879 | $6.23 average | 12K | 2.4% | Form 4 |
| Mar 4 | Noel Donnelly Chief Financial Officer | Sold10b5-1 plan 2 parts | 2,084 | $6.23 average | 13K | 1.8% | Form 4 |
| Mar 4 | James G McArthur President and CEO | Sold10b5-1 plan 2 parts | 5,275 | $6.23 average | 33K | 1.7% | Form 4 |
| Sep 30, 2025 | Oxford Science Enterprises Plc Large holder | Bought | 200,000 | $3.20 | 640K | 4.2% | Form 4 |
| Sep 26, 2025 | RA Capital Healthcare Fund LP Large holder | Bought | 9,375,000 | $3.20 | $30M | 102% | Form 4 |
| May 30, 2025 | Paul Streck EVP, Head of R&D | Bought | 8,375 | $1.24 | 10K | 43% | Form 4 |
| Apr 17, 2025 | James G McArthur President and CEO | Bought | 10,000 | $1.36 | 14K | 9.6% | Form 4 |
| Apr 8, 2025 | James G McArthur President and CEO | Bought | 41,500 | $1.15 | 48K | 66% | Form 4 |
| Feb 26, 2025 | Mary Beth Delena General Counsel | Sold10b5-1 plan | 1,432 | $1.68 | 2K | 48% | Form 4 |
| Feb 26, 2025 | Noel Donnelly Chief Financial Officer | Sold10b5-1 plan | 1,527 | $1.68 | 3K | 48% | Form 4 |
- Nov 13RA Capital Management, L.p.Large holder · bought 8,625,000 at $5.00$43.1M46% of stake
- May 2110b5-1 planKasra KasraianChief Technical Officer · sold 1,233 at $1.412K2.4% of stake
- Mar 410b5-1 planPaul StreckEVP, Head of R&D · sold 1,879 at avg $6.2312K2.4% of stake
- Mar 410b5-1 planNoel DonnellyChief Financial Officer · sold 2,084 at avg $6.2313K1.8% of stake
- Mar 410b5-1 planJames G McArthurPresident and CEO · sold 5,275 at avg $6.2333K1.7% of stake
- Sep 30, 2025Oxford Science Enterprises PlcLarge holder · bought 200,000 at $3.20640K4.2% of stake
- Sep 26, 2025RA Capital Healthcare Fund LPLarge holder · bought 9,375,000 at $3.20$30M102% of stake
- May 30, 2025Paul StreckEVP, Head of R&D · bought 8,375 at $1.2410K43% of stake
- Apr 17, 2025James G McArthurPresident and CEO · bought 10,000 at $1.3614K9.6% of stake
- Apr 8, 2025James G McArthurPresident and CEO · bought 41,500 at $1.1548K66% of stake
- Feb 26, 202510b5-1 planMary Beth DelenaGeneral Counsel · sold 1,432 at $1.682K48% of stake
- Feb 26, 202510b5-1 planNoel DonnellyChief Financial Officer · sold 1,527 at $1.683K48% of stake
Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.
Peers
Pharmaceutical Preparations · Pick stocks to compare with PEPG
Held by ETFs
PEPG is in 5 US ETFs. The largest of them, with PEPG's weight in each:
Spot a number that looks wrong? Check it in PEPG's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing PEPG
A free account gives you 10 stocks a day, a watchlist and price alerts.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.